Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001553350-21-000066
Filing Date
2021-01-20
Accepted
2021-01-20 16:05:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G l1cap_sc13g.htm SC 13G 34286
  Complete submission text file 0001553350-21-000066.txt   36027
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Subject) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13G | Act: 34 | File No.: 005-85256 | Film No.: 21538802
SIC: 2834 Pharmaceutical Preparations

Mailing Address 161A SHEDDEN ROAD ONE ARTILLARY COURT P.O. BOX 10085 GRAND KAYMAN E9 KY1-1001
Business Address 161A SHEDDEN ROAD ONE ARTILLARY COURT P.O. BOX 10085 GRAND KAYMAN E9 KY1-1001 646-688-5654
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by) CIK: 0001702202 (see all company filings)

EIN.: 981241877 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G